> just preserve it or lose just a little Housing generally underperforms the overall market.
Does the data presented in that article really suggest that the apartments are actually empty or is it simply that it takes a while to sell out a new development? It's going to take a while to move a hundred units,…
> It was much better (lighter, simpler, quicker to load) than Java applets from the mid 90s. People often forget about those.
Are there really that many empty apartments? I am sure they exist, but are there really enough of them to make a dent in the market? Having lived in the city for years, I've never actually seen one. I also wonder if you…
There is a section that addresses that specific point: > The Landmarks Preservation Board protects the facades of historic buildings, but not their interiors. Thus landmarking led townhouses once divided into multiple…
Technically, Queens is part of Long Island.
Speaking of distinguishing subtle differences in blues, there is actually a linguistic component. English and Russian color terms divide the color spectrum differently. Unlike English, Russian makes an obligatory…
I am looking here and it's great: http://ggplot2.tidyverse.org/reference/aes.html
This is super controversial, but no need to use Jupyter. I personally find that Jupyter feels like a hack compared to something like RStudio. You have to open a terminal and launch a web server?
A non-insignificant fraction of the R community only exists because of Tidyverse.
> less well documented than most R packages I on the other hand, find most R packages provide barely readable documentation. I can just hope that the vignette exists and actually explains the inputs/outputs.
By that theory, you should diversify away from those that are not going to be "superstocks" (in the post, Dell grew 550x and pushed up the entire index). For example, HP or Exxon or UPS will probably do okay, but will…
> you can research growth stocks (e.g. pharmaceutical companies undergoing FDA trials) and pick the promising ones Those FDA trials are expensive. Those companies have many experts in the field that believe those trials…
Each doctor offers hundreds of services/procedures. Each one has a different price. The insurance company needs a certain number of doctors in the network to be competitive and they can't really have hard cutoffs for…
For the doctor, a great benefit of being cash only is you don't have to do billing, a non-trivial task.
Do you think the locals don't already have that info? The soldiers are not invisible.
But aren't the enemies the only ones that matter?
Or you could just not start tracking right at your house. Wait until you get to an intersection, for example.
"If you know ggplot2"... but you need to make a lot of plots to get the hang of ggplot2. The "+" syntax (not sure what the proper name for that is) alone is completely foreign and intimidating. If you want to make great…
Without experiencing base R, you won't appreciate the tidyverse packages, which tend to have more of a learning curve. For example, you can just run boxplot(x) in base R and it will make you a plot. Only after trying to…
This is written for random internet people. Science papers are written for other scientists working in that particular niche. They are not trying to be approachable to the general public.
Shouldn't this set off some alert at Facebook since their likes per visitor rate will be much higher than normal?
Even commercial products (where they have a financial incentive to provide clear and comprehensive instructions) often take a lot of training before they work properly. How can we expect a small research lab to be…
> we see PhD students and post-doc working 70h hours week on experiments with seemingly random results until the randomness goes their way. There are known and tested protocols that can fail. Not every step can be…
> Only about 10% enroll in clinical trials in the US, which only test one drug at a time. Clinical trials in the US test drug combinations and not just single drugs. > With 90% of the patients not enrolled in a clinical…
> just preserve it or lose just a little Housing generally underperforms the overall market.
Does the data presented in that article really suggest that the apartments are actually empty or is it simply that it takes a while to sell out a new development? It's going to take a while to move a hundred units,…
> It was much better (lighter, simpler, quicker to load) than Java applets from the mid 90s. People often forget about those.
Are there really that many empty apartments? I am sure they exist, but are there really enough of them to make a dent in the market? Having lived in the city for years, I've never actually seen one. I also wonder if you…
There is a section that addresses that specific point: > The Landmarks Preservation Board protects the facades of historic buildings, but not their interiors. Thus landmarking led townhouses once divided into multiple…
Technically, Queens is part of Long Island.
Speaking of distinguishing subtle differences in blues, there is actually a linguistic component. English and Russian color terms divide the color spectrum differently. Unlike English, Russian makes an obligatory…
I am looking here and it's great: http://ggplot2.tidyverse.org/reference/aes.html
This is super controversial, but no need to use Jupyter. I personally find that Jupyter feels like a hack compared to something like RStudio. You have to open a terminal and launch a web server?
A non-insignificant fraction of the R community only exists because of Tidyverse.
> less well documented than most R packages I on the other hand, find most R packages provide barely readable documentation. I can just hope that the vignette exists and actually explains the inputs/outputs.
By that theory, you should diversify away from those that are not going to be "superstocks" (in the post, Dell grew 550x and pushed up the entire index). For example, HP or Exxon or UPS will probably do okay, but will…
> you can research growth stocks (e.g. pharmaceutical companies undergoing FDA trials) and pick the promising ones Those FDA trials are expensive. Those companies have many experts in the field that believe those trials…
Each doctor offers hundreds of services/procedures. Each one has a different price. The insurance company needs a certain number of doctors in the network to be competitive and they can't really have hard cutoffs for…
For the doctor, a great benefit of being cash only is you don't have to do billing, a non-trivial task.
Do you think the locals don't already have that info? The soldiers are not invisible.
But aren't the enemies the only ones that matter?
Or you could just not start tracking right at your house. Wait until you get to an intersection, for example.
"If you know ggplot2"... but you need to make a lot of plots to get the hang of ggplot2. The "+" syntax (not sure what the proper name for that is) alone is completely foreign and intimidating. If you want to make great…
Without experiencing base R, you won't appreciate the tidyverse packages, which tend to have more of a learning curve. For example, you can just run boxplot(x) in base R and it will make you a plot. Only after trying to…
This is written for random internet people. Science papers are written for other scientists working in that particular niche. They are not trying to be approachable to the general public.
Shouldn't this set off some alert at Facebook since their likes per visitor rate will be much higher than normal?
Even commercial products (where they have a financial incentive to provide clear and comprehensive instructions) often take a lot of training before they work properly. How can we expect a small research lab to be…
> we see PhD students and post-doc working 70h hours week on experiments with seemingly random results until the randomness goes their way. There are known and tested protocols that can fail. Not every step can be…
> Only about 10% enroll in clinical trials in the US, which only test one drug at a time. Clinical trials in the US test drug combinations and not just single drugs. > With 90% of the patients not enrolled in a clinical…